278 Lab Medicine Fall 2015 | Volume 46, Number 4 www.labmedicine.com Review tissue), enzymatically (using naturally occurring matrixdegrading enzymes such as papain or collagenase), and biologically (using debriding organisms such as maggots). 7 Hyperbaric oxygen can also be used to treat certain types of wounds such as clostridial myonecrosis, necrotizing soft-tissue infections, and selected nonhealing problem wounds. Hyperbaric oxygen stimulates tissue regeneration by increasing oxygen tension to elicit cellular responses such as angiogenesis and collagen production. Increased oxygen has also been shown to inhibit the growth of anaerobes while increasing the respiration of aerobes, which increases the uptake and efficacy of broadspectrum antibiotics by aerobic respiration. 7 Despite diligent care given to patients with acute wounds, treatment often fails in chronically infected wounds. One of the major reasons for treatment failure is that acute infections can lead to the formation of biofilms. 8 It has been shown 9 that less than 10% of acute wounds contain biofilm, whereas as many as 60% of chronic wounds produce this barrier to treatment.
Biofilms
A bacterial biofilm is a structured community of microorganisms encased in an exo-polysaccharide (EPS) or exo-polymeric substance, which adheres to an inert or living surface. 10 Biofilms are polymicrobial and may consist of not only bacterial cells but also fungi, viruses, proteins, extracellular DNA, and other biogenic factors. 11, 12 Biofilm growth helps bacteria because it is protective and increases survival in a hostile environment. The majority of bacteria in most natural 13 and pathogenic 10 ecosystems compose biofilms. A hallmark of biofilm producing infections is that they are highly polymicrobial; it is thought colloquially that naturally occurring biofilms are never caused by a single organism. The polymicrobial nature of biofilm increases infection virulence and complicates treatment.
Biofilm Formation
Biofilm formation is dynamic and typically involves the following 5 steps, as outlined by Stoodley et al. 14 The first step is reversible attachment of the microbe to a surface mediated by pili, flagella, or other surface appendages or specific receptors; the second is irreversible attachment mediated by the secretion of EPS. The third step is cell proliferation, resulting in the formation of a microcolony; the fourth step is growth and differentiation, culminating in a mature biofilm community with characteristic structural features such as water channels and towering clusters of cells. The final step is dispersion of biofilm cells, actively or by passive detachment (Figure 1 ).
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The hallmark of a biofilm is its secretion of EPS. 15 Biofilm EPS serves a variety of purposes to the colony, the most important of which is bacterial attachment to biotic or abiotic surfaces. The EPS layer is a type of house in which the bacteria live, which features a strong foundation and offers protection from the outside environment. EPS is highly refractory to penetration by antimicrobial agents and the immune system. Bacterial EPS is also thought to protect biofilm bacteria from desiccation; to assist in ion exchange; to house and maintain degradation enzymes; and to carry nutrients such as carbon, nitrogen, and phosphorous. 15 Fully developed biofilms (stage 4 of development) exhibit characteristic structures such as mushroom towers and water channels that bring nutrients and water to, and waste away from, the lower layers of the biofilm. 16 The production of many virulence factors, including biofilm formation, has been attributed to cell-tocell communication via quorum sensing (QS).
Mechanisms of Biofilm Virulence
Bacterial cells encased in biofilm EPS are different than free-living, planktonically growing bacteria in that the former are sessile (non-motile) and have reduced These protocols require standardization and further tested in clinical settings. However, they seem to reveal superior and more representative antibiotic-susceptibility patterns, which can improve treatment efficacy of biofilmassociated infections such as chronic wounds.
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Quorum Sensing
Gram-positive and Gram-negative bacteria use QS to accomplish cell-to-cell communication. This communication is mediated by small molecules that can pass freely through membranes or through a membrane channel or protein. This process depends on cell density; when a species of bacteria reaches a critical population mass, the signaling molecules are produced at high enough concentration to alter gene expression, with as many as 5% of the genes in a given genome potentially affected by QS systems. 32 This allows bacteria to coordinate their activity based on population size. Many proteins and virulence factors produced by bacteria are differentially expressed in response to QS, including the genes responsible for biofilm formation.
QS signaling has been discovered in more than 100 microbial species and is associated with dozens of different receptors and effector molecules. QS systems consist of constitutively expressed signal molecules, or autoinducers (AIs), and a corresponding receptor that regulates gene expression when signal concentration has reached threshold concentration. AIs passively diffuse between cells to activate intracellular receptors, which alter gene expression directly, or are actively pumped out of cells to bind to transmembrane receptors (usually 2-component systems), resulting in signal transduction and downstream changes in gene expression ( Figure 2 ).
The universal QS molecule, termed the autoinducer 2 (AI-2), is produced by more than 50 species of grampositive and gram-negative bacteria and can influence numerous activities such as bioluminescence, virulencefactor production, and exoproduct secretion. 33 61 The device is a lid with 96 pegs that fit into the wells of a standard microtiter plate; biofilm grows statically on the pegs Drip-flow reactor 62 An inclined chamber continuously drips nutrient medium onto a microscope slide; biofilm is grown on the slide. The medium runs down the surface of the slide, allowing for dynamic growth Lubbock chronic wound biofilm model 63 Biofilm is grown statically in a test tube in a very rich medium containing nutrient broth, plasma, and red blood cells. A pipette tip can be used as a scaffold CDC biofilm reactor 64 Apparatus that contains chambers submerged in a vessel; growth media is continuously mixed and poured through the chambers, creating dynamic growth of biofilm
CDC, Centers for Disease Control and Prevention.
Review QS has been shown to be important during all 5 stages of biofilm development; however, the specific QScontrolled stages differ between microbes that use different mechanisms of QS. QS was first linked with biofilm formation in 1998 by Davies et al, 41 who showed that P. aeruginosa QS-negative mutants formed extremely weak biofilms with altered architecture and were not as resistant to treatment as biofilms made by QS-competent P. aeruginosa. 41 P. aeruginosa contains at least 39 genes that are regulated by QS systems. 42 QS-deficient mutants of P. aeruginosa are highly attenuated and less virulent in mouse pneumonia 43 and burn 44 models, presumably because they cannot communicate or make robust biofilms. QS has also been linked to biofilm formation in bacterial species other than P. aeruginosa, such as S. aureus 45 and Vibrio cholera.
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Development of Antibiofilm Therapies
A major hallmark of biofilm is the thick layer of EPS that protects the infecting microbial population from the immune system and antimicrobials. An area of current therapeutic research is the development of agents that degrade the EPS layer so already-developed antimicrobials will be effective. These dispersing agents show promise as a future therapy to be used in combination with antibiotics. An example is the enzyme β-amylase, an enzyme produced by oral bacteria that break down polysaccharide bonds; this compound has been reformulated as a dispersing agent to target the polysaccharide bonds of the EPS with in vitro success in degrading biofilm. 47 Other EPS matrix-degrading enzymes include deoxyribonuclease I, a glycoside hydrolases dispersin B, 48, 49 Another approach to antibiofilm therapy is to use diagnostic procedures based in molecular biology, instead of culture-based methods, for the bacterial species in chronic wounds. 20 Molecular-pathogen diagnostic applications allow comprehensive evaluation of the microbial bioburden in chronic wounds, which leads to a more comprehensive and targeted therapeutic approach to wound care. Molecular diagnostics of these wounds use a rapid screen of known, common bacterial genes (including selected known resistance markers) to diagnose common wound pathogens or general bacterial primers, such as ribosomal 16S, to sequence all bacterial species in a specimen and detect species that are difficult to grow or that represent only a small fraction of the infecting bacteria. 57 Rhoads et al 58 demonstrated that molecular diagnostics detect organisms that do not commonly grow under standard wound-culture techniques (especially anaerobes) and that the most common organisms detected via molecular diagnostics versus traditional culture are often extremely different. 58 For example, in decubitus ulcers, culturebased diagnostics detected Enterococcus spp. most frequently, whereas molecular-based diagnostic methods detected Corynebacterium spp. most frequently. Also, for trauma/abscess wounds, culture methods most commonly reported no growth, whereas molecular-based methods detected Staphylococcus spp. most frequently. Of the 105 specimens tested, culture and molecular results agreed only 63% of the time, and in 13% of culturenegative specimens, bacteria were detected via molecular methods.
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Figure 2
Gram-positive and Gram-negative quorum-sensing systems. 48 .5% of patients with chronic wounds treated based on traditional culture-based methods healed completely, versus 62.4% of patients with chronic wounds who were treated based on molecular diagnostics and were fully healed; the latter patients also had significantly shorter healing times. Additionally, in response to implementing molecular diagnostics, use of first-line antibiotics declined in lieu of targeted antibiotics, a strategy that has the potential to attenuate antibiotic resistance. 20 Topical antibiotics, based on the results of molecular diagnostics, have also showed increased effectiveness in wound care. In a study performed by Dowd et al, 59 culture-driven standard-ofcare treatments were compared with a commercially available treatment guided by molecular diagnostics (instead of culture) and personalized topical therapy developed in a compound pharmacy specific to the microbial burden of each patient, as determined by molecular diagnostic testing. A total of 90.4% of patients who received personalized topical therapies experienced complete healing of their wounds and had more than 200% improved odds of healing compared to patients receiving care based on other protocols. 59 The results of these studies demonstrate that personalized topical therapeutic and molecular diagnostic strategies yield statistically improved outcomes for patients afflicted with chronic wounds and that these protocols provide direct, targeted approaches to wound care.
Conclusions
Interest is growing in the clinical microbiology community for adapting established biofilm analysis techniques used in research to determine antimicrobial susceptibility patterns of biofilm bacteria for use in chronic wound treatment. Preliminary data suggest that using these adapted methods to determine antimicrobial susceptibility will increase treatment efficacy. Antibiofilm research has generated many avenues of potential novel therapies, including QS inhibitors and dispersing agents, as well as the use of molecular diagnostic techniques to improve current therapies. Combining biofilm research with therapeutic development has the potential to significantly increase the ability of healthcare providers to effectively treat biofilm infections. LM
